Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio 2020-05-22 07:11
I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7™ in Glioblastoma Multiforme 2020-05-21 20:00
Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology 2020-05-21 08:58
China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction 2020-05-21 04:45
China Biologic Reports Financial Results for the First Quarter of 2020 2020-05-21 04:30
Macrogen Approved for Export of its COVID-19 Test Kit 2020-05-20 21:00
I-Mab Expands Global Presence with New Hong Kong Office 2020-05-20 16:00
Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification 2020-05-20 07:11
SciMount announces FDA approval of SMP-100's IND application for the treatment of Irritable Bowel Syndrome 2020-05-14 18:00
First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors 2020-05-13 20:00
ChemPartner Assists the Mount Sinai Health System in Producing Reagent for COVID-19 Research 2020-05-12 23:03
China Biologic Products to Report First Quarter 2020 Financial Results 2020-05-12 20:30
HJB and Mabspace Biosciences' Development and Manufacturing Agreement for Novel Humanized Claudin18.2 Monoclonal Antibody Accomplished FDA and NMPA IND Clearance 2020-05-08 23:00
Bridge Biotherapeutics Announces the IND Clearance of BBT-176, an EGFR TKI for NSCLC, in South Korea 2020-05-08 07:30
Alterity Therapeutics Limited Releases Its Appendix 4C - Q3 FY20 Quarterly Cash Flow Report 2020-04-30 16:35
Fosun Pharma Invites Chinese and Foreign Experts to Jointly Discuss Prevention and Control Measures of COVID-19 Epidemic in Africa 2020-04-30 00:50
Gracell Reports Data of First-in-human Clinical Trial for Universal TruUCAR™ GC027 in Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia at the AACR Virtual Annual Meeting 2020-04-29 04:00
CARsgen Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for Fully Human Anti-BCMA CAR-T Cells (CT053) for the Treatment of Multiple Myeloma 2020-04-27 18:00
Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody) 2020-04-23 08:00
Clarity Pharmaceuticals Announces US FDA Grants 67Cu-SARTATE™ Orphan Drug Designation for Neuroblastoma 2020-04-21 21:13
1 114 115 116 117 118 159